通过细导管给予肺表面活性物质技术的应用进展  

Progress in the application of pulmonary surfactant instillation via fine catheter technology

作　　者：霍梦月(综述) 梅花[1] 刘春枝(审校)[1] Huo Mengyue;Mei Hua;Liu Chunzhi(Department of Neonatal, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010050, China)

机构地区：[1]内蒙古医科大学附属医院新生儿科,呼和浩特010050

出　　处：《中国小儿急救医学》2019年第8期618-622,共5页Chinese Pediatric Emergency Medicine

基　　金：国家自然科学基金(81260107);内蒙古自治区自然科学基金项目(2015MS(LH)0810,2016MS(LH)0804);内蒙古医科大学附属医院重大项目(NYFY ZD008).

摘　　要：随着新生儿呼吸窘迫综合征治疗方案的日益完善,微创性肺表面活性物质( pulmonary surfactant,PS)治疗技术以其操作更简单、气道损伤更小的优势逐渐被认为是一种更理想的PS给药方式,是早产儿肺保护性策略的一部分.本文就通过细导管给予PS治疗技术的给药方式、优势、研究现状及今后需要解决的问题做一综述.With the improvement of the treatment of neonatal respiratory distress syndrome, minimally invasive pulmonary surfactant(PS)therapy is gradually considered to be a more ideal drug delivery method for PS because of its simpler operation and less airway damage, and it is a part of the lung protective strategy for premature infants.Therefore, this article reviewed the administration methods, advantages, research status and future problems of minimally invasive PS treatment technology.

关 键 词：呼吸窘迫综合征 新生儿 微创 肺表面活性物质治疗 

分 类 号：R722.12[医药卫生—儿科]